BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9799075)

  • 1. Rapidly progressive renal graft failure associated with interferon-alpha treatment in a patient with chronic myelogenous leukemia.
    Bren A; Kandus A; Ferluga D
    Clin Nephrol; 1998 Oct; 50(4):266-7. PubMed ID: 9799075
    [No Abstract]   [Full Text] [Related]  

  • 2. Nephrotic syndrome associated with alpha interferon therapy in chronic myeloid leukemia.
    Budak-Alpdoğan T; Lawrence RA; Bayik M; Akoğlu E
    Clin Nephrol; 1997 Jul; 48(1):59-60. PubMed ID: 9247783
    [No Abstract]   [Full Text] [Related]  

  • 3. Thrombotic microangiopathy associated with alpha-interferon therapy for chronic myeloid leukaemia.
    Galesic K; Bozic B; Racic I; Scukanec-Spoljar M
    Nephrology (Carlton); 2006 Feb; 11(1):49-52. PubMed ID: 16509932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon-alpha-induced focal segmental glomerulosclerosis in chronic myelogenous leukemia: a case report and review of the literature.
    Bremer CT; Lastrapes A; Alper AB; Mudad R
    Am J Clin Oncol; 2003 Jun; 26(3):262-4. PubMed ID: 12796597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. More on interferon-induced cutaneous necrosis.
    Shinohara K
    N Engl J Med; 1995 Nov; 333(18):1222; author reply 1223-4. PubMed ID: 7565992
    [No Abstract]   [Full Text] [Related]  

  • 6. [Preliminary results of interferon alpha treatment for patients with chronic myelogenous leukemia].
    Popławska-Szczygłowska L; Starzyńska J; Chmarzyńska-Mróz E
    Pol Tyg Lek; 1996 May; 51(19-22):283-4. PubMed ID: 9289711
    [No Abstract]   [Full Text] [Related]  

  • 7. Thrombotic microangiopathy associated with interferon therapy for patients with chronic myelogenous leukemia: coincidence or true side effect?
    Ravandi-Kashani F; Cortes J; Talpaz M; Kantarjian HM
    Cancer; 1999 Jun; 85(12):2583-8. PubMed ID: 10375106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fatal bone marrow aplasia during interferon-a treatment in chronic myelogenous leukemia.
    Chiusolo P; Sica S; Laurenti L; Piccirillo N; Giordano G; Leone G
    Haematologica; 2000 Feb; 85(2):212. PubMed ID: 10681733
    [No Abstract]   [Full Text] [Related]  

  • 9. [Interferon-alpha therapy in chronic myelogenous leukemia].
    Ohnishi K
    Rinsho Ketsueki; 2000 Apr; 41(4):275-9. PubMed ID: 10846454
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of chronic myeloid leukemia with interferon-alpha].
    Szomor A; Molnár L; Nagy A; Dávid M; Alizadeh H; Kecskés M; Vidra T; Kereskai L; Pajor L; Losonczy H
    Orv Hetil; 2000 Nov; 141(48):2601-4. PubMed ID: 11141958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Marked reduction of BCR-ABL fusion chromosome positive cells with interferon therapy combined with short-term imatinib in chronic myelogenous leukemia].
    Ajima A; Takayama N; Hasegawa Y; Kojima H; Nagasawa T
    Gan To Kagaku Ryoho; 2003 Nov; 30(12):1997-9. PubMed ID: 14650975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicenter prospective study of interferon-alpha and conventional chemotherapy versus bone marrow transplantation for newly diagnosed patients with chronic myelogenous leukemia. Kouseisho Leukemia Study Group.
    Ohnishi K; Minami S; Ueda T; Nishimura M; Tsubaki K; Takemoto Y; Takeshita A; Sao H; Kageyama S; Ueda R; Ohno R
    Int J Hematol; 2000 Aug; 72(2):229-36. PubMed ID: 11039674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The adverse influence of pretransplant interferon-alpha (IFN-alpha) on transplant outcome after marrow transplantation for chronic phrase chronic myelogenous leukemia increases with the duration of IFN-alpha exposure.
    Beelen DW; Elmaagacli AH; Schaefer UW
    Blood; 1999 Mar; 93(5):1779-10. PubMed ID: 10084816
    [No Abstract]   [Full Text] [Related]  

  • 14. Interferon-associated retinopathy.
    Savant V; Gillow T
    Eye (Lond); 2003 May; 17(4):534-6. PubMed ID: 12802361
    [No Abstract]   [Full Text] [Related]  

  • 15. Interferon alfa-associated anterior ischemic optic neuropathy.
    Fraunfelder FW; Fraunfelder FT
    Ophthalmology; 2011 Feb; 118(2):408-11.e1-2. PubMed ID: 20630599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Interferon-alpha in the treatment of chronic myeloid leukemia].
    Guilhot F
    Rev Prat; 1999 Mar; 49(5):464-6. PubMed ID: 10358394
    [No Abstract]   [Full Text] [Related]  

  • 17. Interferon alpha sensitisation induced fatal renal insufficiency in a patient with chronic myeloid leukaemia: case report and review of literature.
    Colovic M; Jurisic V; Jankovic G; Jovanovic D; Nikolic LJ; Dimitrijevic J
    J Clin Pathol; 2006 Aug; 59(8):879-81. PubMed ID: 16873566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protocol transplant biopsies: an underutilized tool in kidney transplantation.
    Rush D
    Clin J Am Soc Nephrol; 2006 Jan; 1(1):138-43. PubMed ID: 17699200
    [No Abstract]   [Full Text] [Related]  

  • 19. Re: High rate of graft failure in 25 patients with chronic myelogenous leukemia conditioned with a reduced-intensity regimen of 550 cGy total body irradiation and cyclophosphamide for unrelated donor transplantation.
    Hallemeier C
    Biol Blood Marrow Transplant; 2004 Oct; 10(10):726-7. PubMed ID: 15389439
    [No Abstract]   [Full Text] [Related]  

  • 20. Unsuccessful allogeneic and autologous transplants after prolonged interferon-alpha treatment in a pediatric patient with chronic myeloid leukemia.
    Pérez-Caballero C; Maldonado MS; Tamariz R; de Oteyza JP; Muñoz A
    Haematologica; 2000 Jan; 85(1):105-6. PubMed ID: 10629605
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.